<p>(<b>A</b>) Dot plots generated from MCF7 cell exposed to 2, 3 or 5 mT amplitude PEMFs for 60 minutes per day for three days. The histograms above and to the right of each dot plot show the apoptotic cell subpopulation shaded in black. MCF-7 cancer cells treated with 3 mT PEMFs exhibited the greatest separation between viable (right) and non-viable (left) cell populations as well as a higher overall percentage of dead cells. (<b>B</b>) Viability of MCF7 cells after exposure to 3 mT (20 Hz) for 30, 60 or 90 minutes per day for three days. (<b>C</b>) Percentage of MCF7 apoptotic cells detected by IFC in response to 2, 3 or 5 mT PEMFs normalized to its respective control. Each value represents the average of 4 independent experiments (1 repl...
<p>Cells were treated with or without 1 µg/mL DBP-maf for 48 hours, propidium iodide and annexin V w...
<p>The apoptosis rate was detected by flow cytometry using the Annexin V-fluorescein isothiocyanate/...
<p>(3A) Tumor-bearing untreated control group (Group II) versus (3B) EAF treated, tumor-bearing grou...
<p>(<b>A</b>) Overlay of MCF7 cell populations treated with 2, 3 or 5 mT PEMF amplitudes at 20 Hz fo...
<p>(<b>A</b>) The percentage dead MCF-7 and MCF-10 cells after exposure to 2, 3 or 5 mT PEMFs at a f...
<p>(<b>A</b>) Dot plots generated from MCF7 cells after exposure to PEMFs of 2, 3 or 5 mTs and in co...
<p>(<b>A</b>) Overlay of MCF7 cells treated with 3 mT PEMFs for 60 min/day for 1, 2 or 3 consecutive...
<p>(<b>A</b>) 3 mT PEMFs for 60 min/day impaired MCF7 cancer cell viability sufficiently to cause a ...
<p>(<b>A</b>) Comparison of the dot plots (left) and amplitude histograms (left (above, inset) and r...
<p>MCF7 (cancer) and MCF10 (non-tumorigenic) cells were treated with the PEMF paradigms producing th...
<p>Values refer to the box plots of <a href="http://www.plosone.org/article/info:doi/10.1371/journal...
<p>(A) Replica plates for the same experiment in <a href="http://www.plosone.org/article/info:doi/10...
<p>The first set of experiments included four groups: KTC-1 cells received no treatment (<b>A</b>), ...
<p>Histograms showing the total number of cells (dark grey) and the total number of dead cells (tryp...
BACKGROUND: To study the apoptotic process in time, we used the following flow cytometric (FCM) tech...
<p>Cells were treated with or without 1 µg/mL DBP-maf for 48 hours, propidium iodide and annexin V w...
<p>The apoptosis rate was detected by flow cytometry using the Annexin V-fluorescein isothiocyanate/...
<p>(3A) Tumor-bearing untreated control group (Group II) versus (3B) EAF treated, tumor-bearing grou...
<p>(<b>A</b>) Overlay of MCF7 cell populations treated with 2, 3 or 5 mT PEMF amplitudes at 20 Hz fo...
<p>(<b>A</b>) The percentage dead MCF-7 and MCF-10 cells after exposure to 2, 3 or 5 mT PEMFs at a f...
<p>(<b>A</b>) Dot plots generated from MCF7 cells after exposure to PEMFs of 2, 3 or 5 mTs and in co...
<p>(<b>A</b>) Overlay of MCF7 cells treated with 3 mT PEMFs for 60 min/day for 1, 2 or 3 consecutive...
<p>(<b>A</b>) 3 mT PEMFs for 60 min/day impaired MCF7 cancer cell viability sufficiently to cause a ...
<p>(<b>A</b>) Comparison of the dot plots (left) and amplitude histograms (left (above, inset) and r...
<p>MCF7 (cancer) and MCF10 (non-tumorigenic) cells were treated with the PEMF paradigms producing th...
<p>Values refer to the box plots of <a href="http://www.plosone.org/article/info:doi/10.1371/journal...
<p>(A) Replica plates for the same experiment in <a href="http://www.plosone.org/article/info:doi/10...
<p>The first set of experiments included four groups: KTC-1 cells received no treatment (<b>A</b>), ...
<p>Histograms showing the total number of cells (dark grey) and the total number of dead cells (tryp...
BACKGROUND: To study the apoptotic process in time, we used the following flow cytometric (FCM) tech...
<p>Cells were treated with or without 1 µg/mL DBP-maf for 48 hours, propidium iodide and annexin V w...
<p>The apoptosis rate was detected by flow cytometry using the Annexin V-fluorescein isothiocyanate/...
<p>(3A) Tumor-bearing untreated control group (Group II) versus (3B) EAF treated, tumor-bearing grou...